Elekta gets orders totalling $17 million:
This article was originally published in Clinica
Radiation oncology and neurosurgery company Elekta has signed agreements to deliver its Leksell gamma knife equipment to the US, Japan and Italy for a total order value of SKr160m ($17m). The deliveries, which include a prefabricated treatment room for the gamma knife, are scheduled for 2002-4, the Stockholm, Sweden-based company says.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.